Andrew J Aguirre

51PUBLICATIONS
551CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

|Aug 05, 2026
A dependency map enhanced with next-generation 3D cancer models.

|Jul 17, 2026
Iron overload suppresses LKB1 and induces IL36G anti-tumor immunity in PDAC metastasis.

|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

|Mar 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.

Sofia Ferreira, Brittany M Flowers, Won-Young Choi

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

Pageof 9

Frequent Collaborators

24 joint publications

Brian M Wolpin

14 joint publications

Harshabad Singh

13 joint publications

Kimberly Perez

11 joint publications

Douglas A Rubinson